首页> 美国卫生研究院文献>other >Meta-analysis of the adverse events associated with extended-release versus standard immediate-release pramipexole in Parkinson disease

【2h】

Meta-analysis of the adverse events associated with extended-release versus standard immediate-release pramipexole in Parkinson disease

机译：对帕金森病中与缓释普拉克索和标准速释普拉克索相关的不良事件进行荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:In order to increase treatment choices for patients with Parkinson disease (PD), we performed a retrospective assessment of adverse events associated with a novel once-daily extended-release (ER) formulation versus the standard immediate-release (IR) of the nonergolinic dopamine agonist, pramipexole.

机译：背景：为了增加帕金森病（PD）患者的治疗选择，我们对与每日一次的新型缓释（ER）制剂和标准速释（IR）制剂相关的不良事件进行了回顾性评估非人体工程学多巴胺激动剂普拉克索。

著录项

期刊名称 other
作者
Zhengze Shen; Deping Kong;
展开▼
作者单位

展开▼
年(卷),期 -1(97),34
年度 -1
页码 e11316
总页数 6
原文格式 PDF
正文语种
中图分类
关键词
adverse event meta-analysis Parkinson disease pramipexole;

机译：不良事件;荟萃分析;帕金森病;普拉克索;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson's disease: Results from an open-label study [J] . TakanashiM., ShimoY., HatanoT., Drug research . 2013,第12期

机译：普拉克索曾经每日延长释放制剂的疗效和安全性从晚期帕金森病患者的立即释放制剂转换：开放标签研究的结果
2. Efficacy and safety of extended-versus immediate-release pramipexole in Japanese patients with advanced and L-dopa-undertreated Parkinson disease: A double-blind, randomized trial [J] . MizunoY., YamamotoM., KunoS., Clinical neuropharmacology . 2012,第4期

机译：长期和左旋多巴治疗的帕金森病日本患者延长口服速释普拉克索的疗效和安全性：一项双盲，随机试验
3. Efficacy and safety of pramipexole extended-release in Parkinson's disease: a review based on meta-analysis of randomized controlled trials [J] . Shen T., Ye R., Zhang B. European journal of neurology: the official journal of the European Federation of Neurological Societies . 2017,第6期

机译：帕金森病中普拉肯脂延长的疗效和安全性：基于荟萃分析的随机对照试验的综述
4. A transition-based model for jointly extracting drugs, diseases and adverse drug events [C] . Fei Li, Donghong Ji, Xiaomei Wei, IEEE International Conference on Bioinformatics and Biomedicine . 2015

机译：基于过渡的模型，用于联合提取毒品，疾病和不良药品事件
5. Preventing adverse cardiovascular events in women with clinically diagnosed periodontal disease. [D] . DeFelice, Debra Ann. 2012

机译：在临床诊断为牙周疾病的妇女中预防心血管不良事件。
6. Population Pharmacodynamics of IPX066: An Oral Extended-Release Capsule Formulation of Carbidopa–Levodopa and Immediate-Release Carbidopa–Levodopa in Patients With Advanced Parkinson’s Disease [O] . Zhongping Mao, Ann Hsu, Suneel Gupta, -1

机译：IPX066的群体药效学：晚期帕金森病患者口服卡比多巴-左旋多巴和速释卡比多巴-左旋多巴的口服缓释胶囊制剂
7. Meta-analysis of the adverse events associated with extended-release versus standard immediate-release pramipexole in Parkinson disease [O] . Zhengze Shen, Deping Kong 2018

机译：与帕金森病中延长释放与标准立即释放普拉米脂溢置相关的不良事件的荟萃分析

Meta-analysis of the adverse events associated with extended-release versus standard immediate-release pramipexole in Parkinson disease

摘要

著录项

相似文献

相关主题

期刊订阅